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mGluR1 receptors contribute to non-purinergic slow excitatory 
transmission to submucosal VIP neurons of guinea-pig ileum
Jaime Pei Pei Foong* and Joel C. Bornstein
Department of Physiology, University of Melbourne, Parkville, Australia
Vasoactive intestinal peptide (VIP) immunoreactive secretomotor neurons in the submucous 
plexus are involved in mediating bacterial toxin-induced hypersecretion leading to diarrhoea. VIP 
neurons become hyperexcitable after the mucosa is exposed to cholera toxin, which suggests 
that the manipulation of the excitability of these neurons may be therapeutic. This study 
used standard intracellular recording methods to systematically characterize slow excitatory 
postsynaptic potentials (EPSPs) evoked in submucosal VIP neurons by different stimulus regimes 
(1, 3 and 15 pulse 30 Hz stimulation), together with their associated input resistances and 
pharmacology. All slow EPSPs were associated with a significant increase in input resistance 
compared to baseline values. Slow EPSPs evoked by a single stimulus were confirmed to be 
purinergic, however, slow EPSPs evoked by 15 pulse trains were non-purinergic and those 
evoked by 3 pulse trains were mixed. NK1 or NK3 receptor antagonists did not affect slow 
EPSPs. The group I mGluR receptor antagonist, PHCCC reduced the amplitude of purinergic 
and non-purinergic slow EPSPs. Blocking mGluR1 receptors depressed the overall response 
to 3 and 15 pulse trains, but this effect was inconsistent, while blockade of mGluR5 receptors 
had no effect on the non-purinergic slow EPSPs. Thus, although other receptors are almost 
certainly involved, our data indicate that there are at least two pharmacologically distinct types 
of slow EPSPs in the VIP secretomotor neurons: one mediated by P2Y receptors and the other 
in part by mGluR1 receptors.
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the conductance changes underlying these events with early studies 
indicating that they are due to a decrease in membrane k+ conduct-
ance (Bornstein et al., 1986; Mihara et al., 1985; Surprenant, 1984), 
but a recent report that they are due to increased cation conductance 
(Hu et al., 2003). Further, an early study reported that only neurons 
with the electrophysiological properties of VIP neurons are depo-
larized by substance P (Surprenant, 1984), but histochemical stud-
ies indicate that VIP neurons do not express tachykinin receptors 
(Jenkinson et al., 1999; Moore et al., 1997). Another complication 
comes from the report that some submucosal neurons are depolar-
ized by the NK1 receptor agonist septide, but are not immunoreactive 
for NK1 tachykinin receptors (Moore et al., 1997).
There is a similar lack of clarity, when one considers another 
candidate transmitter, glutamate. Group I metabotropic 1α and 
5 glutamate receptors (mGluR1α and mGluR5) have been found 
via immunohistochemistry in submucosal neurons of guinea-pig 
ileum (Hu et al., 1999; Liu and Kirchgessner, 2000). Glutamate, 
and group I mGluR agonists evoke slow depolarizations sensitive 
to S-4- carboxyphenylglycine (S-4CPG, group I mGluR antagonist) 
in submucosal neurons (Hu et al., 1999; Ren et al., 2000), but the 
antagonist did not affect slow EPSPs (Ren et al., 2000). Others 
reported that a mGluR5 selective antagonist, 2-methyl-6-(phenyleth
ynyl)pyridine hydrochloride (MPEP), and S-4CPG depressed slow 
EPSPs in submucosal neurons (Liu and Kirchgessner, 2000), while 
it has also been reported that glutamate acts via group I mGluRs 
to suppress slow EPSPs and potentiate slow IPSPs in submucosal 
neurons (Ren et al., 1999).
IntroductIon
Vasoactive intestinal peptide (VIP) immunoreactive neurons in the 
submucous plexus are the key secretomotor neurons in the enteric 
nervous system (Bornstein and Furness, 1988). Their importance 
is shown by their involvement in the hypersecretion produced by 
cholera toxin and Escherichia coli enterotoxins (Banks et al., 2005), 
the fact that they are the only secretomotor neurons to receive 
input from outside the intestine and their converging input from 
many different enteric neurons (Bornstein and Furness, 1988). 
These neurons exhibit several excitatory and inhibitory potentials 
identified by their time courses and neurotransmitters (Gwynne 
and Bornstein, 2007). These include two types of fast excitatory 
postsynaptic potentials (EPSPs, duration up to 50 ms), mediated 
by nicotinic acetylcholine receptors (Monro et al., 2004; Moore 
and Vanner, 1998; Surprenant, 1984) and P2X purine receptors 
(Monro et al., 2004), two inhibitory postsynaptic potentials (IPSPs; 
Bornstein et al., 1988; Mihara et al., 1987), an EPSP with an inter-
mediate time course (250–750 ms) (Bornstein et al., 1986; Monro 
et al., 2004) and slow EPSPs that can last several tens of seconds 
(Bornstein et al., 1986; Surprenant, 1984). The fast EPSPs and 
IPSPs have been studied extensively, but studies of the slow EPSPs 
have been contradictory.
Several studies have found that slow EPSPs can be evoked in VIP 
neurons by a single stimulus pulse applied to an internodal strand 
(Bornstein et al., 1986; Monro et al., 2004; Surprenant, 1984). This 
slow EPSP is mediated by P2Y1 receptors (Hu et al., 2003; Monro 
et al., 2004). However, there are radically different reports about 
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One explanation for these discrepancies is that stimulus 
regimes differed between studies: trains of stimuli evoke slow 
EPSPs in submucosal neurons that lack responses to single stimu-
lus pulses. However, the relationship between stimulus regime, 
input resistance and pharmacology of slow EPSPs is unknown. 
The present study characterized the input resistance changes 
and pharmacology of slow EPSPs evoked by different stimulus 
regimes in VIP submucosal neurons. The roles of P2, NK1 and 
NK3 tachykinins, and group I mGluR receptors were specifically 
examined.
MaterIals and Methods
tIssue preparatIon
Male or female guinea-pigs (200–400 g) were killed by applying a 
sharp blow to the back of the head and immediately severing the 
carotid arteries and spinal cord, in accordance with the guidelines 
of the University of Melbourne Animal Experimentation Ethics 
Committee (AEEC). A 3–5 cm segment of ileum, 15–30 cm oral to 
the ileo-caecal junction was removed from the abdominal cavity 
and placed in physiological saline solution (composition in mM: 
NaCl 118, NaHCO3 25, D-glucose 11, KCl 4.8, CaCl2 2.5, MgSO4 
1.2, NaH2PO4 1.0), bubbled with 95% O2, 5% CO2. The tissue was 
flushed clean with physiological saline and a 1 × 1.5 cm prepara-
tion of submucous plexus was dissected as described elsewhere 
(Monro et al., 2004) and pinned flat, serosa side up, in an organ 
bath. It was then equilibrated for at least 1 h before recording 
began. The preparation was continually superfused with physi-
ological saline bubbled with 95% O2, 5% CO2 and kept at 33–34°C. 
Idazoxan hydrochloride was added into the superfusing solution 
in some experiments; it does not affect slow EPSPs (Foong and 
Bornstein, 2009).
electrophysIology
Intracellular recordings were made from submucosal neurons 
(Monro et al., 2004). Submucosal ganglia were viewed at 200× 
magnification. A monopolar stimulating electrode (50 μm, non-
insulated tungsten wire) was placed on an internodal strand leading 
to the chosen ganglion and synaptic potentials were evoked by focal 
stimulation. Cells were impaled with glass microelectrodes (100–
200 MΩ, 1 M KCl, with or without 2% biocytin). Hyperpolarizing 
current (0–2 nA) was used to inject biocytin (Sigma Aldrich, Castle 
Hill, NSW, Australia). Stimuli were delivered in 1 pulse (12 V), 
3 pulse (12 V, 30 Hz) and 15 pulse (12 V, 30 Hz) trains to evoke 
IPSPs and slow EPSPs.
Drugs used
Antagonists were added to the superfusate. These were N-
 phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a- carboxamide 
(PHCCC), BAY 36-7620, MPEP (all Tocris Bioscience, East 
Brisbane, QLD, Australia), idazoxan hydrochloride, pyridoxal phos-
phate-6-azo(benzene-2,4-disulfonic acid) (PPADS) (both Sigma 
Aldrich, Castle Hill, NSW, Australia), SR142801 and SR140333 
(gifts from Dr Emonds-Alt, Sanofi Recherche, Montpellier, France). 
All were prepared as stock solutions dissolved in distilled water 
and/or dimethyl sulfoxide (DMSO), kept in aliquots at −20°C and 
dissolved to their final working concentrations in physiological 
saline when used in experiments.
Data analysis and statistics
The mean amplitudes of slow EPSPs and IPSPs were analyzed 
using Axoscope 9.2.0.12 (Axon Instruments, Inc., Union City, CA, 
USA) in control, drug and, where possible, after washout (at least 
15–30 min). All data are presented as mean ± SEM. A two-tailed 
or one-tailed Student’s paired t-test, or repeated measures ANOVA 
were performed. A p < 0.05 was considered to be significant.
IMMunohIstocheMIstry
A subset of electrophysiology preparations was fixed in Zamboni’s 
fixative (2% formaldehyde and 0.2% picric acid in 0.1-M phosphate 
buffer, pH 7.0) at 4°C overnight. They were then cleared of fixative 
and permeabilized using 3 × 10 min washes with DMSO followed by 
3 × 10 min washes with phosphate buffered saline (PBS) and proc-
essed to reveal the presence of VIP and/or biocytin by incubating in 
rabbit anti-VIP antibody (1:500; Euro-Diagnostica, East Brisbane, 
QLD, Australia) for 48 h at room temperature, washing with PBS, 
and incubating with donkey anti-rabbit fluorescein isothiocyanate 
(FITC) antibody (1:40; Amersham Biosciences Pty Ltd, Castle Hill, 
NSW, Australia) and Streptavidin-Texas Red (1:200; Amersham 
Biosciences) for 2.5 h. After removing excess antibody by washing 
with PBS, preparations were mounted on slides in buffered glycerol 
(pH 8.7), and viewed under a fluorescence microscope.
results
A total of 213 neurons were impaled in 67 preparations and 72 neu-
rons were studied in detail as they had stable impalements and dis-
played slow EPSPs. Pharmacological experiments were conducted 
on 34 of the 72 neurons characterized.
slow epsps, Ipsps and IMMunoreactIvIty for vIp
IPSPs were evoked by trains (3 or 15 pulse) of focal stimuli in 69 
out of the 72 neurons. Idazoxan (2 μM), which depresses IPSPs, 
was present for two of the other three neurons. IPSPs identify VIP 
neurons, as they are confined to this neuronal subtype (Bornstein 
et al., 1986; Evans et al., 1994). In our study, 28 of the 69 neurons 
with IPSPs were filled with biocytin, all were immunoreactive for 
VIP. Six neurons that lacked IPSPs were filled with biocytin, none 
were immunoreactive for VIP.
All 34 neurons that were used for pharmacology displayed fast 
EPSPs, followed by intermediate EPSPs or IPSPs and then slow 
EPSPs in response to a 1 (22 of 34), 3 (31 of 34) and/or 15 pulse 
(30 of 34) stimulus (Figures 1A–C). Slow EPSPs vary in duration, 
some do not even return to baseline. The 1 pulse evoked slow EPSPs 
had amplitudes of 7.7 ± 0.6 mV (n = 36) and durations ranging 
from 4.4 to 26.8 s (n = 29), 3 pulse slow EPSPs had amplitudes of 
9.8 ± 0.7 mV (n = 48) and durations from 5.7 to 35.6 s (n = 40) and 
15 pulse slow EPSPs had amplitudes of 10.1 ± 0.6 mV (n = 44) and 
durations from 8.2 to 41.8 s (n = 40).
slow epsps are assocIated wIth an Increase In Input 
resIstance
Hyperpolarizing pulses (0.1 nA, 60–80 ms, 1 Hz) were used to 
measure the change in input resistance associated with slow EPSPs. 
The amplitude of the hyperpolarization evoked by a current pulse 
at the baseline membrane potential and that of one from the peak 
of the slow EPSP were measured for each stimulus protocol. Input 
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resistances were calculated from these values and are shown in 
Figure 1D. Each stimulus regime produced a significant increase 
in input resistance: for 1 pulse, the increase was 30 ± 4 MΩ (n = 32, 
p < 0.0001, Figures 1A,D); for 3 pulse trains, the increase was 
37 ± 4 MΩ (n = 42, p < 0.0001, Figures 1B,D); for 15 pulse trains, 
the increase was 58 ± 12 MΩ (n = 38, p < 0.0001, Figures 1C,D).
ppads reversIbly abolIshed 1 pulse slow epsps but had no 
effect on 15 pulse slow epsps
PPADS (30 μM) reversibly abolished 1 pulse slow EPSPs (n = 6, 
p < 0.0001, Figures 2A,D), but as reported previously (Monro 
et al., 2004) had no effect on mean membrane potential in these 
neurons. The amplitudes of 3 pulse slow EPSPs were significantly 
smaller in PPADS, but there was a PPADS-insensitive component 
(n = 4, p < 0.05, Figures 2B,D) and post hoc analysis showed that 
the significant difference was between the drug treatment and the 
washout. The amplitudes of 15 pulse slow EPSPs were unaffected 
by PPADS (n = 4, p = 0.52, Figures 2C,D). Thus, we refer to 1 pulse 
slow EPSPs as purinergic slow EPSPs and 15 pulse slow EPSPs as 
non-purinergic slow EPSPs.
tachykInIn receptor antagonIsts dId not affect slow epsp 
aMplItudes
Possible roles for NK1 tachykinin receptors in slow EPSPs evoked 
in VIP neurons were tested using the specific NK1 receptor antago-
nist SR140333 at a concentration (200 nM) that depresses slow 
EPSPs in myenteric neurons (Johnson and Bornstein, 2004). SR 
140333 had no effect on the purinergic (n = 4, p = 0.12), 3 pulse 
(n = 4, p = 0.21) or the non-purinergic (n = 4, p = 0.7) slow EPSPs 
(Figure 3A).
Possible roles for NK3 tachykinin receptors in the slow EPSPs of 
VIP neurons were tested using the specific NK3 receptor antagonist 
SR142801 at a concentration that blocks slow EPSPs in myenteric 
neurons (Johnson and Bornstein, 2004). SR 142801 (200 nM) did 
not affect purinergic (n = 3, p = 0.56), 3 pulse (n = 3, p = 0.07) or 
non-purinergic (n = 3, p = 0.9) slow EPSPs (Figure 3B).
phccc reversIbly reduced the aMplItude of purInergIc and 
non-purInergIc slow epsps
Roles for group I metabotropic glutamate receptors were ini-
tially tested using the group I mGluR antagonist PHCCC, at a 
concentration that we have found to depress colonic propulsion. 
PHCCC (30 μM) reversibly reduced the amplitude of purinergic 
(n = 4, p < 0.05) and non-purinergic (n = 6, p < 0.01) slow EPSPs. 
However the reduction in the amplitude of 3 pulse slow EPSPs 
was not significant in the presence of PHCCC (n = 4, p = 0.1) 
(Figure 4A).
effects of specIfIc antagonIsts on mglur1 and mglur5 
receptors
To determine if mGluR1 receptors play a role in the slow EPSPs of 
VIP neurons, the specific mGluR1 antagonist BAY 36-7620 (10 μM) 
was tested against responses to 1, 3 and 15 pulse trains. A one-tailed 
test was used to minimize the number of neurons analyzed, as the 
FiGuRE 1 | input resistance associated with slow EPSPs. Examples of (A) 1 pulse, (B) 3 pulse and (C) 15 pulse evoked slow EPSPs in a submucosal neuron. 
(D) Quantified data comparing input resistance at baseline (arrows) and that associated with 1, 3 and 15 pulse slow EPSPs (arrows).
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PHCCC results indicated that a decrease in the slow EPSP ampli-
tude was to be expected. BAY 36-7620 did not affect the amplitude 
of purinergic slow EPSPs (n = 6, p = 0.20), but reduced the ampli-
tudes of 3 pulse slow EPSPs (n = 11, p = 0.048) and non-purinergic 
slow EPSPs (n = 11, p = 0.037) (Figure 4B).
When individual neurons were examined, BAY 36-7620 was 
found to reduce the amplitude of three pulse slow EPSPs in six 
neurons, but caused a slight increase (two neurons) or had no 
effect (three neurons) in others. Similarly, its effects on 15 pulse 
non-purinergic slow EPSPs were variable: six neurons showed a 
marked reduction in slow EPSP amplitude, but others showing 
no effect (three neurons) or a slight increase (two neurons). Three 
neurons whose slow EPSPs were depressed by BAY 36-7620 were 
held long enough to wash out the drug and in each case the slow 
FiGuRE 2 | Effects of PPADS (30 μM) on slow EPSPs. (A) 1 pulse (12 V), (B) 3 pulse (30 Hz) and (C) 15 pulse evoked slow EPSPs in control, PPADS and after 
washout. (D) Quantified data for slow EPSPs evoked by 1, 3 and 15 pulses.
FiGuRE 3 | Effects of (A) SR 140333 (200 nM) and (B) SR 142081 (200 nM) on slow EPSPs. Quantified data for purinergic (1 p), 3 pulse (3 p) and non-purinergic 
(15 p) slow EPSPs.
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EPSPs recovered. Effects on purinergic one pulse slow EPSPs were 
examined in four of the neurons whose 15 pulse slow EPSPs were 
depressed and the one pulse responses were increased in two neu-
rons, reduced in one neuron and unchanged in the last.
In contrast, the specific mGluR5 receptor antagonist MPEP 
(10 μM, previously reported to be effective on submucosal slow 
EPSPs (Liu and Kirchgessner, 2000) had no significant effect on 
either three pulse (n = 5, p = 0.25 one-tailed paired t-test) or non-
purinergic (n = 4, p = 0.23) slow EPSPs (Figure 4C).
dIscussIon
This is the first time the input resistance, pharmacology and stimuli 
regimes have been studied together to characterize slow EPSPs in 
VIP secretomotor neurons of the submucosal plexus. The results 
show that sensitivity to blockade of P2 receptors is stimulus regime 
dependent with single pulses evoking slow EPSPs that appear to be 
entirely due to P2 receptor activation and 15 pulse trains evoking 
responses that are insensitive to blockade of these receptors. Both 
the purinergic slow EPSPs and the non-purinergic slow EPSPs were 
associated with an increase in input resistance at the peak of the 
response suggesting they are due to a decrease in K+ conductance. 
The non-purinergic EPSPs are not mediated by tachykinins acting 
at either NK1 or NK3 receptors, but a subset are probably mediated 
by mGluR1 receptors with others mediated by neurotransmitter/
receptor combinations that remain to be identified.
the pharMacology of slow epsps In vIp neurons depends on 
the stIMulus that evokes theM
The finding that slow EPSPs evoked by single pulses applied to an 
internodal strand are blocked by the P2 receptor antagonist PPADS 
is consistent with previous reports that such slow EPSPs are medi-
ated by P2Y1 receptors (Hu et al., 2003; Monro et al., 2004). We 
used PPADS rather than a more specific P2Y1 antagonist, because 
Monro et al. (2004) had shown that PPADS and the specific P2Y1 
antagonist were equally effective against one pulse slow EPSPs in 
these neurons. Earlier studies showed that only the VIP neurons, 
i.e. those that exhibit IPSPs, respond to single pulse stimuli with 
slow EPSPs (Bornstein et al., 1986; Surprenant, 1984). Monro et al. 
(2004) found that these neurons exhibit fast EPSPs mediated by 
P2X receptors and a novel class of EPSP with intermediate dura-
tions of 250–750 ms that are also mediated by P2Y1 receptors. 
Thus, the VIP neurons of guinea-pig submucosal plexus receive 
a prominent purinergic input producing three different classes 
of EPSP.
Previous studies did not test whether altering the stimulus 
changes the character of the slow EPSPs. While Bornstein et al. 
(1986) showed that increasing the number of pulses in a train 
increased the amplitude and duration of the slow EPSPs in VIP 
neurons; they detected no other differences in the characteristics 
of these slow EPSPs. Similarly, Surprenant (1984) concluded that 
responses to trains of stimuli were no different to those evoked by 
individual stimuli. Hu et al. (2003) reported that some VIP neurons 
had purinergic and non-purinergic slow EPSPs, which could be 
distinguished by underlying conductance changes, but provided no 
details of stimulus regime. This present study shows that slow EPSPs 
evoked by long trains of stimuli in VIP neurons differ qualitatively 
from those evoked by individual stimulus pulses, because they are 
insensitive to blockade of P2 receptors. As VIP neurons are the 
major secretomotor neurons in the intestine, this distinction may 
have important functional consequences.
both purInergIc and non-purInergIc slow epsps are 
assocIated wIth Increased Input resIstance
The present results support earlier findings that all slow EPSPs 
in VIP neurons involve increased input resistance, due to inac-
tivation of K+ conductance (Bornstein et al., 1986; Mihara et al., 
1985; Surprenant, 1984). However, they contrast markedly with 
FiGuRE 4 | Effects of (A) PHCCC (30 μM), (B) BAY 36-7620 (10 μM) and 
(C) MPEP (10 μM) on slow EPSPs. Statistical analysis used two-tailed 
ANOVA for PHCCC and one-tailed paired t-tests for MPEP and BAY 36-7620.
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the report of Hu et al. (2003) that purinergic slow EPSPs are 
mediated by increased non-specific cation conductance, with 
only non-purinergic slow EPSPs being mediated by decreased 
K+ conductance. These contrasting findings are very difficult to 
reconcile, although there are some differences in experimental 
protocols. For example, Hu et al. (2003) reported that input resist-
ance was reduced during the depolarizing phase of purinergic 
slow EPSPs, while we measured input resistance at the peak of 
the slow EPSPs to avoid contamination from occult IPSPs and 
intermediate EPSPs. However, this does not account for the dis-
tinction between earlier findings that slow EPSPs, including those 
evoked by one pulse, reverse at about −90 mV (Bornstein et al., 
1986; Surprenant, 1984) and the report from Hu et al. (2003) that 
purinergic slow EPSPs reverse at about −4 mV. One possibility is 
that P2Y1 receptors produce three distinct conductance changes. 
They appear to mediate intermediate EPSPs via opening a chloride 
channel (Monro et al., 2004) and perhaps they open a non-specific 
cation channel and close a k+ channel with the contributions of 
each depending on the background conditions of the experiment. 
If so, the relevant conditions remain unclear.
transMItters MedIatIng the non-purInergIc slow epsps In vIp 
neurons
Substance P (SP) acting on NK1 receptors has often been considered 
a candidate for a neurotransmitter mediating slow EPSPs in sub-
mucosal neurons. Bath application (Surprenant, 1984) or pressure 
ejection of SP (Mihara et al., 1985; Ren et al., 2000) both depolarize 
submucosal neurons. Furthermore, although VIP neurons appar-
ently lack immunoreactivity for NK1 receptors (Moore et al., 1997), 
NK1 agonists evoke NK1 antagonist sensitive slow depolarizations in 
submucosal neurons that are not immunoreactive for NK1 receptors 
(Moore et al., 1997). Most of these neurons had IPSPs (Moore et al., 
1997) indicating that they were VIP neurons. However, our finding 
that the non-purinergic slow EPSPs were unaffected by SR 140333 
indicates that NK1 receptors do not mediate slow EPSPs in VIP 
neurons. Similarly, the finding that the NK3 antagonist SR 142801 
had no effect on slow EPSPs in VIP neurons indicates that NK3 
receptors do not mediate slow EPSPs in these neurons. Although 
the number of neurons tested with the tachykinin antagonists are 
small, these data are consistent with an earlier report that slow 
EPSPs are seen in VIP neurons after all SP-immunoreactive termi-
nals had degenerated after lesions to both extrinsic and intrinsic 
neural pathways (Bornstein et al., 1988).
The conclusion that tachykinins do not play a role in synaptic 
transmission to VIP neurons does not exclude roles for them in 
transmission to other submucosal neurons. Immunohistochemical 
studies indicate that both NK1 (Moore et al., 1997) and NK3 recep-
tors (Jenkinson et al., 1999) are expressed by cholinergic secreto-
motor neurons and tachykinin immunoreactive neurons that may 
be intrinsic sensory neurons. Further, studies of mucosal secretion 
indicate that tachykinins excite secretomotor neurons (Frieling 
et al., 1999, Larsson et al., 2008).
The other transmitter candidate whose role we investigated was 
glutamate acting on group I metabotropic glutamate receptors. The 
data indicate that mGluR1 receptors mediate a component of the 
non-purinergic slow EPSPs in some VIP neurons. This is consistent 
with the finding that submucosal neurons express mGluR1   receptors 
(Hu et  al., 1999). Although submucosal neurons also express 
mGluR5 receptors (Hu et al., 1999; Liu and Kirchgessner, 2000), 
we found no evidence that these mediate slow EPSPs in VIP neu-
rons. This was surprising because immunoreactivity for mGluR5 has 
been reported to colocalize with VIP in submucosal neurons (Liu 
and Kirchgessner, 2000). However, different groups have reported 
that activation of mGluRs increase (Liu and Kirchgessner, 2000; 
Ren et al., 2000), decrease (Hu et al., 1999; Ren et al., 2000) or did 
not change the input resistance (Ren et al., 2000) of submucosal 
neurons, with no obvious explanation for the discrepancy. Our 
finding that input resistance is increased during non-purinergic 
slow EPSPs mediated in part by mGluR1 receptors is consistent with 
the first observation. However, our observation that MPEP had no 
effect on slow EPSPs contrasts with the report that this antagonist 
at a similar concentration depressed submucosal slow EPSPs (Liu 
and Kirchgessner, 2000). One possible confounding factor that may 
explain some, but not all, discrepancies is that focal stimulation 
of a single internodal strand does not activate every input to the 
impaled neuron (Bornstein et al., 1986). This may result in a selec-
tive proportion of nerve inputs to be stimulated each time, causing 
difficulty in interpretation of the data.
Another possible explanation for some of the discrepancies 
comes from the report that glutamate suppresses slow EPSPs and 
potentiates slow IPSPs in S-type submucosal neurons via group I 
mGluRs (Ren et al., 1999). Glutamate also suppresses slow depo-
larizations evoked by SP and 5-HT as well as hyperpolarizations 
evoked by NA (Ren et al., 1999). This suggests that glutamate may 
have a modulatory role in neurotransmission.
The conclusion that mGluR1 receptors play a significant role 
depends on the specificity of BAY 36-7620. This compound has 
been shown to be highly selective for mGluR1 receptors over other 
metabotropic glutamate receptors (Carroll et al., 2001); however, its 
cross-reactions with other putative transmitters are not known. It 
appears that PHCCC may cross-react with P2Y1 receptors, because 
it depressed the purinergic one pulse slow EPSPs. In contrast, BAY 
36-7620 had no effect on the purinergic one pulse slow EPSPs, 
and thus can discriminate between P2Y1 and mGluR1 receptors. 
Whether it interacts with the variety of other putative transmitter 
receptors that might be involved (see below) was beyond the scope 
of this study.
Group I mGluRs are positively coupled to phospholipase 
C (PLC), while group II (mGluR2 and mGluR3) and group III 
(mGluR4 and mGluR6–8) are negatively coupled to adenylate 
cyclase (Coutinho and Knopfel, 2002; Schoepp et  al., 1999). 
Group I mGluRs are generally localized postsynaptically, but 
there is evidence that presynaptic group I mGluRs reduce gluta-
matergic transmission in the central nervous system (Manzoni 
and Bockaert, 1995). Group II and III mGluRs are mostly presy-
naptic and act as autoreceptors to decrease neurotransmission 
(Coutinho and Knopfel, 2002). Group II mGluR-immunoreactiv-
ity is present in the submucous plexus of rat jejunum and ileum 
(Larzabal et al., 1999). mGluR8 immunoreactivity can be local-
ized to the plasma membrane of VIP immunoreactive neurons in 
the submucous plexus of the rat ileum (Tong and Kirchgessner, 
2003). Thus, glutamate transmission may be modulated by 
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autoreceptors present in the submucous plexus and hence may 
have multiple roles.
While the results implicate mGluR1 receptors in some slow 
EPSPs of VIP neurons, they also clearly indicate that other neuro-
transmitter receptor combinations are involved. Several potential 
candidates have been identified in the literature. Pan and Gershon 
(2000) suggested that calcitonin gene-related peptide is involved 
in transmission from intrinsic sensory neurons to submucosal 
neurons, while Kordasti et al. (2006) suggested a role for VIP. VIP 
neurons are depolarized by 5-HT (Surprenant and Crist, 1988) and 
are excited by low concentrations of this compound to generate 
secretory responses in isolated preparations of submucosa/mucosa 
(Cooke and Carey, 1985; Johnson et al., 1994). The slow EPSPs are 
not mediated by 5-HT7 receptors (Foong and Bornstein, 2009), but 
there has been no exhaustive study of the role of 5-HT.
conclusIons
This study shows that the VIP neurons of the submucosal plexus 
exhibit two qualitatively different slow EPSPs that can be distin-
guished by their sensitivity to P2 receptor antagonists and the 
stimulus regimes that evoke them. While there is evidence that 
P2 mediated slow EPSPs play a role in the regulation of secre-
tion in the colon, whether they play a role in the small intes-
tine is unknown. However, overactivity of VIP neurons plays 
a critical role in the hypersecretion produced by cholera toxin 
and some other toxins that produce secretory diarrhoea (Banks 
et al., 2005; Gwynne et al., 2009; Kordasti et al., 2006). Cholera 
toxin indirectly causes VIP neurons to become hyperexcitable 
(Gwynne et al., 2009), but how the purinergic and non-purin-
ergic slow EPSPs interact with this is unknown. Blockers of P2Y1 
receptors or mGluR1 receptors may have interesting effects on 
cholera-induced diarrhoea and perhaps on other forms of diar-
rhoea also.
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